More on CXM

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (2.0 Score)
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (9/9/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CXM Cash Flow Statement

Click line-items for a historical chart and %
Net loss -3.24M
Gain on sale of discontinued operation
Gain on sale of warrants
Loss on abandonment of leaseholds
Depreciation 7.68K
Amortization-intangibles
Amortization-debt discount
Amortization-deferred financing costs
Amortization-technology and product license fee
Provision for obsolete inventory 0
Change in fair value of warrants
Common stock and warrants issued for services and reimbursement of expenses
Stock based compensation expense 961.22K
In-process purchased technology
Accounts receivable
Inventories
Prepaid expenses and other assets 183.13K
Deposits
Accounts payable 416.98K
Accrued liabilities 432.67K
Deferred rent
Net cash used in operating activities
In-process technology purchased from Tissue Repair Company
Fee paid to list shares issued for technology and product license
Purchases of property and equipment
Net cash used in investing activities
Proceeds from officer loan
Cash acquired in acquisitions
Restricted cash - collateral for letter of credit
Restricted cash - proceeds placed in escrow from sale of business
Proceeds from the exercise of warrants, net
Proceeds from debt financing agreement, net of debt issuance costs of $871,833
Proceeds from the sale of business unit
Repayment of debt
Proceeds from sales of common stock, net of issuance cost 600K
Net cash provided by financing activities
Net increase (decrease) in cash -198.52K
Cash and cash equivalents at beginning of period 216.73K
Cash and cash equivalents at end of period 18.22K
Cash paid for interest 4.49K
Cash paid for income taxes
Subscription receivable for common shares
Common stock issued for repayment of loans
Stock issued for technology license fee
Net assets acquired for the issuance of common stock (exclusive of cash acquired)
Warrants exchanged for stock
Reclassification of derivative liabilities with expired price protection provisions
Issuance of note for accrued milestone payment

Entities mentioned with CXM

View All Entities